Beatty S. Non-organic visual loss. Postgrad Med J. 1999 Apr;75(882):201-7.
Bain KE, Beatty S, Lloyd C. Non-organic visual loss in children. Eye (Lond). 2000 Oct;14 Pt 5:770-2.
Bose S, Kupersmith MJ. Neuroophthalmologic presentations of functional visual disorders. Neurol Clin. 1995 May;13(2):321-39.
McBain VA, Robson AG, Hogg CR, Holder GE. Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials. Graefes Arch Clin Exp Ophthalmol. 2007 Apr;245(4):502-10. Epub 2006 Nov 17.
Kusunoki S. Diagnosis, pathogenesis and treatment of Miller Fisher syndrome and related disorders: clinical significance of antiGQ1b IgG antibody. Expert Rev Neurother. 2003 Jan;3(1):133-40.
Toru S, Ohara M, Hane Y, Ishiguro T, Kobayashi T. Successful steroid treatment for recurrent Miller Fisher syndrome. Muscle Nerve. 2012 May;45(5):763-4.
Faulstich ME, Carnrike CL Jr, Williamson DA. Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches. 15 J Psychosom Res. 1985;29(1):89-94.
Defazio G, Lamberti P, Lepore V, Livrea P, Ferrari E. Facial dystonia: clinical features, prognosis and pharmacology in 31 patients. Ital J Neurol Sci. 1989 Dec;10(6):553-60.
Nutt JG, Hammerstad JP, Carter JH, deGarmo P. Meige syndrome: treatment with trihexyphenidyl. Adv Neurol. 1983;37:201-5.
Miyazaki Y, Sako W, Asanuma K, Izumi Y, Miki T, Kaji R. Efficacy of zolpidem for dystonia: a study among different subtypes. Front Neurol. 2012;3:58. Epub 2012 Apr 17.
Boshes RA, Afonso JA, Tanev K. Treatment of Meige's syndrome with ECT. J ECT. 1999 Jun;15(2):154-7.
Sako W, Morigaki R, Mizobuchi Y, Tsuzuki T, Ima H, Ushio Y, Nagahiro S, Kaji R, Goto S. Bilateral pallidal deep brain stimulation in primary Meige syndrome. Parkinsonism Relat Disord. 2011 Feb;17(2):123-5. Epub 2010 Dec 13.
